Nanox Imaging Ltd. (NASDAQ: NNOX) has entered into a distribution agreement with SOLME RC, S.A., a Costa Rica-based medical equipment distributor, to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The agreement, announced in a press release, positions Nanox to penetrate a new market in Central America, following its recent entries into Argentina and Peru. This move underscores the company's strategy to drive the global transition to preventive healthcare by making advanced imaging more accessible and affordable.
Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support for the Nanox.ARC in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. This relationship could facilitate adoption within the public healthcare system, potentially accelerating the technology's integration into routine care. Commercialization will proceed after applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This phased approach allows for clinical validation and adaptation to local requirements, which is critical for building trust among healthcare providers.
The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. Unlike traditional CT scanners, which are often bulky and expensive, the Nanox.ARC aims to bring 3D imaging to a broader range of clinical settings, including those with limited resources. By providing affordable hardware, Nanox seeks to lower barriers to adoption and improve utilization. The system is part of a larger ecosystem that includes Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; and Nanox.MARKETPLACE, which offers access to remote radiology and cardiology experts through teleradiology services. This integrated approach enables a seamless workflow from scan to interpretation, which could enhance clinical efficiency and support earlier detection of disease.
The agreement with SOLME is significant because it expands Nanox's footprint in Latin America, a region where access to advanced medical imaging is often limited. Costa Rica represents Nanox's third Latin American market this year, following Argentina and Peru, indicating a focused effort to address underserved areas. By partnering with a local distributor that has established ties to the CCSS, Nanox can navigate regulatory and logistical challenges more effectively. This could lead to faster adoption and demonstrate the scalability of Nanox's model in diverse healthcare environments. For investors, the news signals progress in commercializing the Nanox.ARC and validates the company's strategy of targeting markets with a high need for affordable imaging solutions.
Moreover, the agreement aligns with Nanox's vision to expand the reach of medical imaging both within and beyond traditional hospital settings. The company's end-to-end platform combines imaging hardware, AI, cloud infrastructure, and access to remote expertise, aiming to improve patient outcomes and advance preventive care worldwide. As healthcare systems globally grapple with rising costs and the need for early disease detection, Nanox's solutions could offer a viable alternative to conventional imaging equipment. The Costa Rica deal not only adds a new revenue stream but also serves as a proof point for the company's ability to execute on its international expansion plans. The latest news and updates relating to NNOX are available in the company's newsroom at http://ibn.fm/NNOX.
